Elevated plasma P-selectin levels (>44.3 ng/mL) were associated with an increased risk of incident venous thromboembolism in women (OR 1.63; 95% CI 1.01-2.64), but not in men.
Case-Control (n=1,258)
Are elevated plasma P-selectin levels associated with an increased risk of future incident venous thromboembolism?
Elevated plasma P-selectin levels are associated with an increased risk of incident VTE in women, suggesting a sex-specific biomarker role.
Effect estimate: OR 1.63 (95% CI 1.01-2.64)
BACKGROUND: P-selectin levels are elevated following acute deep vein thrombosis and reported to predict recurrent venous thromboembolism (VTE) and cancer-associated VTE. Yet, it is unknown whether plasma P-selectin levels are associated with incident VTE. OBJECTIVES: We aimed to investigate the association between plasma P-selectin levels and risk of future incident VTE. METHODS: We performed a nested case-control study in 415 patients with VTE and 843 age- and sex-matched controls derived from the general population (Tromsø IV Study). Plasma P-selectin levels were measured using enzyme-linked immunosorbent assay. Logistic regression models were used to estimate odds ratios (ORs) for VTE across quartiles of plasma P-selectin level. Sex-stratified analysis was also performed. RESULTS: Plasma P-selectin levels were higher in men (41.4 ng/mL) than in women (38.7 ng/mL, p = .0046). We found no association between plasma P-selectin levels and risk of VTE in the overall analyses. However, sex-stratified analyses revealed that women with P-selectin levels in the highest quartile (>44.3 ng/mL) had higher risk of VTE (OR, 1.63; 95% CI, 1.01-2.64) than women with P-selectin levels in the lowest quartile (≤29.9 ng/mL). In contrast, higher levels of P-selectin were apparently associated with lower risk of VTE in men (OR for highest vs lowest quartile of P-selectin, 0.69; 95% CI, 0.42-1.15). The observed associations were stronger when the time between blood sampling and VTE was shorter. CONCLUSION: Elevated levels of plasma P-selectin were associated with increased risk of VTE in women but not in men, suggesting a differential impact of sex on the association between P-selectin and VTE risk.
Swamy et al. (Fri,) conducted a case-control in Venous thromboembolism (n=1,258). Plasma P-selectin levels vs. Lowest quartile of P-selectin (≤29.9 ng/mL) was evaluated on Incident venous thromboembolism (OR 1.63, 95% CI 1.01-2.64). Elevated plasma P-selectin levels (>44.3 ng/mL) were associated with an increased risk of incident venous thromboembolism in women (OR 1.63; 95% CI 1.01-2.64), but not in men.